Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Aokang Biotech is a specialized biotechnology company based in Chengdu, China, focusing on the research, development, and large-scale production of natural plant extracts and active pharmaceutical ingredients (APIs). The company is a leading global manufacturer of bioflavonoids, notably Rutin, Quercetin, Troxerutin, and L-Rhamnose, primarily derived from the Sophora japonica plant. Their high-purity products serve the pharmaceutical, nutraceutical, and cosmetic industries, supporting applications in cardiovascular health and anti-inflammatory treatments. Operating with modern manufacturing facilities, the company adheres to international quality standards including GMP, ISO, and Kosher certifications. Chengdu Aokang Biotech's expertise lies in standardized botanical extraction and advanced purification technologies. By providing reliable, high-quality natural compounds, the company has established a significant presence in both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Aokang Biotech.